Skip to main content

SB 5594 — Washington

Concerning biosimilar medicines.

Introduced 2025-2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • SB 5594 is a bill in the Washington Senate, 2025-2026 session, introduced January 30, 2025.
  • Sponsored by Harris, with 3 cosponsors.
  • Current status: introduced.
  • Most recent action (March 12, 2026): By resolution, returned to Senate Rules Committee for third reading.
  • 2 recorded votes; the most recent, on January 21, 2026, passed 49-0.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Harris

Cosponsors (3): Cleveland, Hasegawa, Shewmake

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate First reading, referred to Health & Long-Term Care.
  2. Senate Public hearing in the Senate Committee on Health & Long-Term Care at 10:30 AM.
  3. Senate Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM.
  4. Senate HLTC - Majority; 1st substitute bill be substituted, do pass.
  5. Senate Passed to Rules Committee for second reading.
  6. Senate Placed on second reading by Rules Committee.
  7. Senate 1st substitute bill substituted (HLTC 25).
  8. Senate Floor amendment(s) adopted.
  9. Senate Rules suspended. Placed on Third Reading.
  10. Senate Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.

    3rd Reading & Final Passage (#7): 49 yes 0 no Passed, 100% yes

  11. House First reading, referred to Health Care & Wellness.
  12. House Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
  13. House Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM.
  14. House By resolution, returned to Senate Rules Committee for third reading.
  15. Senate By resolution, reintroduced and retained in present status.
  16. Senate Rules Committee relieved of further consideration.
  17. Senate Placed on third reading.
  18. Senate Rules suspended.
  19. Senate Returned to second reading for amendment.
  20. Senate Floor amendment(s) adopted.
  21. Senate Rules suspended. Placed on Third Reading.
  22. Senate Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.

    3rd Reading & Final Passage (#11): 49 yes 0 no Passed, 100% yes

  23. House First reading, referred to Health Care & Wellness.
  24. House Public hearing in the House Committee on Health Care & Wellness at 8:30 AM.
  25. House Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
  26. House HCW - Majority; do pass.
  27. House Referred to Rules 2 Review.
  28. House By resolution, returned to Senate Rules Committee for third reading. Latest

Source: Open States. Last checked November 1, 2026. How we keep this accurate ›